EICHORPublic-registry site landscape for NCT04377945, “Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components”, a Dyskinesias study sponsored by Bukwang Pharmaceutical. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04377945 (registry record) |
| Study title | Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study in Parkinson's Disease Patients With Dyskinesia to Assess the Efficacy and Safety/Tolerability of Fixed Dose Combinations of JM-010 and Its Individual Components |
| Sponsor | Bukwang Pharmaceutical |
| Condition(s) | Dyskinesias; Parkinson Disease |
| Phase | PHASE2 |
| Listed sites | 2 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT04377945.
Eichor generates a preliminary site-risk snapshot for NCT04377945 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Dyskinesias trials
← Eichor home · All tracked trials · Dyskinesias studies · Weekly briefs
